Intellia Therapeutics is a leading genome editing company focused on developing proprietary, curative therapeutics using the CRISPR/Cas9 system. Intellia believes the CRISPR/Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course, and through improved cell therapies that can treat cancer and immunological diseases, or can replace patients’ diseased cells. The combination of deep scientific, technical and clinical development experience, along with its leading intellectual property portfolio, puts Intellia in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create a new class of therapeutic products. read more

EMPLOYEE PARTICIPANTS: 12

TOTAL RATINGS: 170

CEO: John Leonard

HR or Marketing? Claim Your Free Employer Account

Intellia Therapeutics KPIs and OKRs

Employees’ understanding of Intellia Therapeutics' KPIs and OKRs is essential for its success. Out of 1 Intellia Therapeutics employees who’ve answered, “Are your company’s goals clear and are you invested in them?” 1 have said yes.

Answer	Percent
Yes	100%
No	0%

Are your company's goals clear, and are you invested in them?

Answer	Percent
Yes	0%
No	0%

Are the KPIs/OKRs for your department clear?

Manager's Role in Accomplishing Goals

A main function of a managerial role is to lead one’s subordinates. A manager at Intellia Therapeutics is responsible for ensuring his subordinates accomplish objectives using key performance indicators. Intellia Therapeutics employees shared they generally receive helpful feedback every week. Feedback and positive reinforcement are both conducive to meeting goals.